GlassScriptPhysician profile
Silki Pankajkumar Modi
NPI 1407411895
$674.71
in general payments reported to CMS, 2019-2025
12 companies · $450 in 2025
The $450 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $24.18 · 2024: $200 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $225.12 | 2024-2025 | |
| Shield Therapeutics INC | $83.82 | 2024-2025 | |
| Evofem Biosciences, INC. | $79.00 | 2024-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $71.94 | 2024-2025 | Myfembree |
| Hologic Sales and Service, LLC | $41.79 | 2025 | Aptima, Thinprep 2000 Processor, Fetal Fibronectin Enzyme Immunoassay |
| Optumhealth Care Solutions, LLC | $36.97 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Becton, Dickinson and Company | $30.55 | 2025 | Arista |
| Solventum Corporation | $24.34 | 2025 | Prevena |
| Astellas Pharma US INC | $24.18 | 2023 | Veozah |
| Biogen, INC. | $23.88 | 2025 | Zurzuvae |
| Organon LLC | $16.97 | 2024 | |
| Abbvie INC. | $16.15 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Silki Modi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.